✨ Medicines and Corrections Notices




NEW ZEALAND GAZETTE, No. 38 β€” 28 APRIL 2016

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Morphine Juno 100mg/5mL
Morphine hydrochloride trihydrate 20mg/mL
equivalent to morphine base 15.18mg/mL
Solution for injection
Juno Pharmaceuticals NZ Limited
L Molteni & C Dei F lli Alitti Societa di Esercizio SpA, Firenze, Italy

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Opdivo 40mg/4mL
Nivolumab 10mg/mL
Concentrate for infusion
Bristol-Myers Squibb (NZ) Limited
Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Opdivo 100mg/10mL
Nivolumab 10mg/mL
Concentrate for infusion
Bristol-Myers Squibb (NZ) Limited
Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Paracetamol Hot Lemon Lime Drink
Paracetamol 500mg
Oral granules
Multichem NZ Limited
Cipla Limited, Pithampur, India

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Paracetamol Hot Lemon Lime Drink
Paracetamol 1000mg
Oral granules
Multichem NZ Limited
Cipla Limited, Pithampur, India

Dated this 21st day of April 2016.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

2016-go2347

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Privigen
Normal immunoglobulin 100g/L
Solution for infusion
CSL Behring (NZ) Limited
CSL Behring AG, Bern, Switzerland
CSL Behring LLC, Illinois, United States of America

Dated this 21st day of April 2016.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

2016-go2348

Notice of Variation of a Security Contract

Pursuant to Section 170(2) of the Corrections Act 2004

On 4 April 2016, Her Majesty The Queen, in the Right of New Zealand, acting by and through the Chief Executive of the Department of Corrections, and Serco New Zealand Limited, varied a security contract that was entered into under section 166(1) of the Corrections Act 2004.

35



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2016, No 38





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
21 April 2016
Medicines Act 1981, New Medicines, Distribution, Morphine, Opdivo, Paracetamol
  • CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health

πŸ₯ Consent to the Distribution of a New Medicine

πŸ₯ Health & Social Welfare
21 April 2016
Medicines Act 1981, New Medicine, Distribution, Privigen
  • CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health

βš–οΈ Notice of Variation of a Security Contract

βš–οΈ Justice & Law Enforcement
Corrections Act 2004, Security Contract, Variation, Serco New Zealand Limited